U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
Casgevy uses the Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans.
Source link
Casgevy uses the Nobel Prize-winning technology CRISPR to treat sickle cell disease, a blood disorder that affects about 100,000 Americans.
Source link
/cloudfront-us-east-2.images.arcpublishing.com/reuters/YKBRYL4XCNKHFKR7D2DZA7UQSA.jpg "Australia’s reopening plans stumble as Omicron cases rise"){kind=small}
